About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
1 10, 2025

Maneesha Ghiya Talks Femtech and the Future of Women’s Healthcare

By |2025-10-01T17:53:10+03:00October 1, 2025|Fitness News, News|0 Comments

When it comes to innovations in healthcare, Maneesha Ghiya means business.

As a venture capitalist and investor at hedge funds, the Harvard Business grad has spent more than 25 years — pretty much her entire career — investing in healthcare.

But when a medical emergency almost took her life, Ghiya saw firsthand the need for innovation in women’s healthcare specifically. So, she started her own venture capital firm, FemTech Ventures, to fill that gap.

FemTech Ventures partners with businesses to advance women’s health through medications, devices, digital and artificial intelligence, and diagnostics (imaging, tests and tools).

The firm’s investment approach looks at women’s health conditions in three ways: “Only women” (endometriosis), “mostly women” (breast cancer) and “differently in women” (heart disease).

“We created and published this framework in 2019, and it has since been adopted by many others across the healthcare industry. By defining women’s health more broadly, we are able to identify and bring forward innovations that address conditions across women’s health,” Ghiya said.

We asked Ghiya for her thoughts on the technology-based solutions that are making waves in women’s health, and how her own health scare inspired her passion for change.

Our interview follows, edited for clarity and length.

HealthyWomen: Tell us about your experience with postpartum hemorrhage and how it led to the launch of FemTech Ventures?

Maneesha Ghiya: When I gave birth to my daughter at Columbia University under the care of a top OB-GYN, I encountered serious complications.

What began as an emergency C-section turned into a crisis with an undetected internal bleed. Four surgeons performed a reoperation that was ultimately unsuccessful in locating the source, and I was transferred to the ICU, where I underwent 10 transfusions of blood and platelets.

Fortunately, my body caught up with the bleed, and I survived. But that ordeal fueled a desire for me to make a difference in women’s health, which led me to found FemHealth Ventures.

Read: Postpartum Hemorrhage Is a Deadly Problem >>

HW: Historically, we know that women’s health has been overlooked and underfunded. How is femtech helping to broaden interest in women’s health?

Ghiya: We invest in drugs, devices, diagnostics, and digital and artificial intelligence in the women’s health space. We consider femtech a subset of women’s health and would see any software or AI platforms tailored towards women’s health falling into our digital and AI investment focus.

For example, we invested in a company called Cercle. Cercle AI’s product analyzes patient records within a fertility clinic, allowing doctors to quickly access data on how similar cases were treated, including protocols, success rates and side effects.

This helps optimize treatment plans, leading to higher success rates — which, for those familiar with the IVF journey, is incredibly impactful.

Read: Infertility Isn’t Just a Physical Journey — It’s an Emotional One, Too >>

HW: What are you finding most exciting in the world of femtech right now?

Ghiya: I’m excited to see how AI and robotics can raise the standard of care across medical centers.

One exciting application we see in the robotics and AI category is for needle-based procedures. For instance, consider epidurals during labor — 1 in 10 either fail or need adjustment because each person has a different anatomy, which makes it challenging even for experts to achieve precise needle placement.

One of our portfolio companies, Mendaera, has created a robotic needle-guidance device that combines ultrasound imaging with robotic delivery.

Beyond epidurals, this technology can be applied to procedures like nerve blocks and breast biopsies. This is a game changer because, previously, only highly skilled clinicians could perform these types of procedures with efficiency and accuracy. With this robotic and AI guidance system, more clinicians can deliver needle-based care more precisely, which is highly impactful for patients who may not have access to major medical centers.

HW: Since launching FemHealth Ventures, tell us about a product/innovation that has been particularly memorable for you.

Ghiya: We were very excited when our portfolio company Gynesonics was acquired in January by Hologic. Currently, more than 200,000 women in the U.S. undergo hysterectomies each year due to the severe and often debilitating symptoms of fibroids.

Gyenosonics offers a new solution: a non-surgical, outpatient procedure using radiofrequency ablation. The procedure is incision-free, allowing women to return to work as soon as the next day — compared to the months-long recovery associated with surgery. Thanks to Gynesonics, hundreds of thousands of women will avoid hysterectomies. It was exciting to see this amazing innovation be brought to more women through this acquisition.

HW: What big advancements are you hoping to see in women’s healthcare in the near future, or what should we have on our radar?

Ghiya: I am excited to see more solutions for women in the postpartum depression (PPD) space. Unfortunately, maternal mortality rates in the U.S. have been on the rise in recent years, with PPD being a significant contributor. In response to this urgent need, we invested in Reunion Neurosciences, which is developing a breakthrough drug therapy to address PPD.

It involves a one-time, four-hour treatment administered in a specialized facility by trained medical professionals [and has shown promising results in clinical trials]. The drug therapy is currently undergoing a full FDA trial and approval process and will only be available under medical supervision.

Read: When Postpartum Depression Hit, I Heard Only the Lies My Depression Told Me >>

HW: What’s your advice for how readers can help support innovations in femtech?

Ghiya: We encourage anyone interested in supporting women’s health to stay informed.

My company regularly posts articles on our LinkedIn about key updates in the women’s health space and updates from our women’s health focused portfolio companies. A great example of a recent update in the women’s health space is the Gates Foundation pledging $2.5 billion to women’s health initiatives. We are thrilled to see the growing focus and momentum in the women’s health space.

From Your Site Articles

Related Articles Around the Web



Source link

1 10, 2025

Natural gas price achieves the breach– Forecast today – 01-10-2025

By |2025-10-01T16:34:43+03:00October 1, 2025|Forex News, News|0 Comments


Natural gas price activated with the main indicators’ positivity, breaching the resistance at $3.290 level, to settle within the main bullish channel’s levels, achieving some gains by reaching 3.365.

 

Forming main support at $3.280 level, besides the continuation of providing positive momentum by the main indicators, we expect forming a new bullish rally to surpass $3.410 level, to target the next station at 3.350.

 

The expected trading range for today is between $3.300 and $3.530

 

Trend forecast: Bullish





Source link

1 10, 2025

USD All Over the Place Against JPY

By |2025-10-01T16:29:51+03:00October 1, 2025|Forex News, News|0 Comments

  • The US dollar initially rallied against the Japanese yen during the trading session here on Tuesday to reach towards the 149 yen level but then pulled back significantly to break below the 200 day EMA at least for part of the session. The 50 day EMA also offer support. So now that we have, it has shown itself to be a little bit more resilient. I think you’ve got a situation where traders just aren’t willing to go too deep into the market as the non-farm payroll uh comes out on Friday.
  • That being said, I think you still have to favor the upside due to the swap differential. The interest rate differential still favors the US dollar regardless, and if we can break above the 149 yen level, I think we have a real shot at going to the 150 yen level, possibly even 151 yen. Anything about that then becomes buy and hold. I have been buying dips along the way for several months now.
  • And I think that is going to be how I continue to play this market. Just simply collecting swaps to get paid, to hang on to the trade and then collecting my gains as they occur.

On a Break Lower

If we were to break down below the 146 yen level, then it’s likely that we really will start to fall apart, perhaps reaching down to the 143.50 yen level. The market remains a little bit noisy, but really that’s not a huge surprise. Just think of all of the drama going on at the same time. And with that being the case, it’s difficult for people to get overly aggressive in any particular position. That includes the dollar against the yen, but over the longer term, I still prefer the US dollar over the yen, at least until we break down below the 146 yen level.

Want to trade our USD/JPY forex analysis and predictions? Here’s a list of forex brokers in Japan to check out.

Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.

Source link

1 10, 2025

Tryptophan Market Size, Share | CAGR of 7.4%

By |2025-10-01T16:26:35+03:00October 1, 2025|Dietary Supplements News, News|0 Comments


Report Overviews

The Global Tryptophan Market size is expected to be worth around USD 1480.0 Million by 2034, from USD 724.8 Million in 2024, growing at a CAGR of 7.4% during the forecast period from 2025 to 2034. In 2024 Asia Pacific held a dominant market position, capturing more than a 40.5% share, holding USD 293.5 Million in revenue.

Tryptophan is one of the 20 standard amino acids and an essential amino acid for humans and animals. It serves as a building block for proteins and a precursor to important substances such as the neurotransmitter serotonin, the hormone melatonin, and vitamin B3 (niacin).

Tryptophan Market Size, Share | CAGR of 7.4%

Tryptophan is essential for the human body; however, the body cannot synthesize it, which makes it important to obtain it from the diet. As the awareness regarding the well-being of the body increases, it creates opportunities for tryptophan to be utilized in food supplements and pharmaceuticals.

Similarly, in animals, tryptophan improves growth performance, reduces stress and regulates insulin, synthesizes protein in the muscles, and improves meat quality. The use of the amino acid in animal feed is the major driver of the market. Furthermore, the market faces challenges due to the regulatory framework and quality control. Moreover, with ongoing technological advancements, the market is expected to experience steady and sustained growth.

  • Annual tryptophan production is estimated at 41,000 metric tons yearly, with China leading the production.

Key Takeaways

  • The global tryptophan market was valued at USD 724.8 million in 2024.
  • The global tryptophan market is projected to grow at a CAGR of 7.4% and is estimated to reach USD 1480.0 Million by 2034.
  • Based on grades, feed grade tryptophan dominated the market in 2024, comprising about 72.8% share of the total global market.
  • Based on the type of tryptophan, L-tryptophan dominated the market with approximately 94.8% of the total market share.
  • Among the applications of tryptophan, the animal feed industry dominated the market in 2024, accounting for around 72.8% of the market share.
  • Asia Pacific was the largest market for tryptophan in 2024, accounting for around 40.5% of the total global consumption.

Grade Analysis

Feed Grade Tryptophan Dominated the Market in 2024.

On the basis of grades of tryptophan, the market is segmented into feed and food grades. Feed-grade tryptophan dominated the market in 2024 with a market share of 72.8%. Feed-grade tryptophan is more widely utilized due to its cost-effectiveness and the high demand for amino acids in livestock nutrition. Animal feed formulations require tryptophan to improve growth rates, feed conversion ratios, and overall animal health, especially in poultry, swine, and aquaculture.

Feed-grade tryptophan is produced under less stringent purity standards compared to food-grade, making it more affordable for large-scale animal farming operations. Additionally, the formulation of feed-grade tryptophan typically prioritizes quantity over ultra-high purity. Conversely, food-grade tryptophan is manufactured to meet higher quality standards, often for human consumption, where higher purity and safety are crucial. As a result, the agricultural sector’s demand for affordable, high-volume ingredients makes feed-grade tryptophan more prevalent in the market.

Type Analysis

L-Tryptophan Emerged as a Leading Segment in the Market in 2024.

Based on the types of tryptophan, the market is divided into L-tryptophan and D-tryptophan. L-tryptophan dominated the market in 2024 with a market share of 94.8%. L-tryptophan is more widely utilized than D-tryptophan due to its superior bioavailability and role in biological processes. L-tryptophan is the naturally occurring isomer in both humans and animals, and it serves as a precursor to important neurotransmitters such as serotonin and melatonin, which regulate mood and sleep.

The body can readily absorb and metabolize L-tryptophan, making it highly effective in supplements aimed at improving mental health and sleep quality. In contrast, D-tryptophan is not readily incorporated into biological systems and has limited biological activity. Consequently, L-tryptophan is preferred in both dietary supplements and animal feed, as it provides the desired physiological effects and is more easily utilized by the body.

Application Analysis

In 2024, the Tryptophan Market was Primarily Driven by the Animal Feed Industry.

Among the applications of tryptophan, in 2024, the animal feed industry was at the forefront of the market, with a total global market share of 72.8%. More tryptophan is used in animal feed than in food, dietary supplements, or pharmaceuticals due to its essential role in promoting optimal growth, health, and productivity in livestock. Tryptophan is a key amino acid in animal nutrition, crucial for protein synthesis, immune function, and overall metabolism.

In the livestock and poultry industries, large quantities of tryptophan are required to ensure efficient feed conversion, improve digestive health, and enhance growth rates. The demand for high-quality, nutrient-rich animal feed is driven by the growing global consumption of meat and dairy products. While tryptophan is also used in supplements and pharmaceuticals, its application in animal feed remains dominant due to the larger scale and cost-efficiency needed to support the agriculture industry’s high-volume demands, making it a central component in animal nutrition formulations.

Tryptophan Market ShareTryptophan Market Share

Key Market Segments

By Grade

By Type

  • L-Tryptophan
  • D-Tryptophan

By Application

  • Animal Feed
  • Food & Dietary Supplements
  • Pharmaceuticals
  • Others

Drivers

Growing Demand from the Animal Feed Sector Drives the Tryptophan Market.

The increasing demand from the animal feed sector has been a significant driver for the growth of the tryptophan market. Tryptophan, an essential amino acid, is crucial for the growth, development, and overall health of livestock. It plays a pivotal role in improving feed efficiency, boosting immunity, and promoting better reproductive performance in animals. With the rising global consumption of meat and dairy products, the need for high-quality animal feed has surged.

  • For instance, global average per capita meat consumption increased from 41.4 kg in 2012 to 44.5 kg in 2022.

Similarly, global poultry meat consumption neared 133 million metric tons in 2024. The poultry farming has seen substantial demand for tryptophan, as it helps in enhancing egg production and improving meat quality. Furthermore, the aquaculture industry has increasingly adopted tryptophan-rich feeds to optimize fish health and growth rates. The demand for tryptophan in animal nutrition continues to rise, supporting its prominent role in the feed industry.

Restraints

Regulatory Framework and Quality Control Pose a Significant Challenge in the Tryptophan Market.

The regulatory framework and quality control remain significant challenges in the tryptophan market, particularly as stricter safety and quality standards are enforced globally. Tryptophan, being a bioactive compound, is subject to rigorous regulations to ensure its safe use in dietary supplements, animal feed, and pharmaceuticals. For instance, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) impose stringent guidelines on the manufacturing processes, labeling, and safety testing of tryptophan-based products.

Compliance with these regulations can be costly and time-consuming for producers. Additionally, ensuring consistent product quality and purity is a constant challenge, as contamination or impurities in tryptophan can lead to adverse effects, as seen in the 1989 outbreak of eosinophilia-myalgia syndrome linked to contaminated tryptophan. To mitigate such risks, companies must invest in robust quality control systems, including rigorous testing and certification processes, to maintain consumer trust and meet regulatory standards.

Opportunity

Increased Use in Dietary Supplements Boosts the Tryptophan Market.

The growing use of tryptophan in dietary supplements presents significant opportunities in the market, driven by increasing awareness of its health benefits. Tryptophan is a precursor to serotonin, a neurotransmitter that regulates mood, sleep, and appetite, making it a popular ingredient in supplements aimed at improving mental well-being. According to a study released by the World Health Organization in September 2025, more than a billion people are living with mental health disorders, with conditions such as anxiety and depression inflicting immense human and economic tolls. As mental health concerns rise globally, the demand for natural supplements to promote relaxation and alleviate symptoms of anxiety, depression, and insomnia has increased.

For instance, tryptophan is commonly found in sleep aids, with studies showing its ability to improve sleep quality. Additionally, as more consumers seek natural alternatives to pharmaceutical treatments, tryptophan’s role in supporting overall cognitive function, mood stability, and immune health has further fueled its popularity in the wellness industry. Furthermore, as consumer preferences shift, several companies are integrating tryptophan in their functional beverages. For instance, in March 2024, Nestlé launched Yiyang Wanning, a milk powder containing mulberry leaf extract, tryptophan, vitamin B, magnesium, and zinc in China.

Trends

Focus on Technological Advancements.

Technological advancements are playing a key role in the evolution of the tryptophan market, enhancing both production efficiency and product quality. For instance, innovations in biotechnology, particularly microbial fermentation, have revolutionized tryptophan manufacturing by enabling higher yields with reduced environmental impact. Companies are increasingly adopting genetically engineered microorganisms to produce tryptophan, improving the purity and consistency of the final product.

Additionally, chemical modification strategies, including photo-and electrochemical methods, are expanding tryptophan’s use in drug development, materials science, and environmental monitoring. Microbial synthesis of 5-HTP, a precursor to serotonin, is improving through enzyme evolution and the introduction of substrate pathways, providing a fast and environmentally friendly alternative to traditional extraction. Similarly, biomanufacturing methods are expanding to produce industrially relevant tryptophan derivatives such as 7-chloro-L-tryptophan and 7-bromo-L-tryptophan. Modified tryptophan derivatives are used in drug discovery and development, including potential therapeutic applications.

Geopolitical Impact Analysis

Geopolitical Tensions Leading to Supply Chain Disruptions in the Tryptophan Market.

Geopolitical tensions have a notable impact on the tryptophan market, particularly due to disruptions in global supply chains, trade restrictions, and raw material availability. Countries that produce key raw materials for tryptophan, such as corn and soy, may face export bans or tariffs due to geopolitical conflicts, leading to price volatility and supply shortages.

  • For instance, the United States produces around 28% of the world’s soy and around 31% of the world’s corn, and China is the largest market for feed additives, including tryptophan. However, due to trade tensions between the countries have affected the global feed and supplement markets.

Additionally, the production of tryptophan is an energy-intensive process, where conflict between countries leads to a rise in prices of energy, which directly affects the price of the production of the compound, leading to a surge in the price. For instance, the conflict between Russia and Ukraine has led to a doubling of the price of oil.

Similarly, the conflicts in the Middle East and Eastern Europe have hindered the flow of key ingredients and surges in the energy prices. These disruptions force companies to seek alternative sourcing strategies, often increasing costs and lead times. Such uncertainties affect the pricing and the availability of tryptophan, leading to challenges in maintaining consistent production and meeting market demand.

Regional Analysis

Asia Pacific was the Largest Market for Tryptophan in 2024.

Asia Pacific held the major share of the global tryptophan market, valued at around US$293.5 million, commanding an estimated 40.5% of the total revenue share. Asia Pacific stands as the largest market for tryptophan, driven by its rapidly expanding animal feed and dietary supplement industries. The region, particularly countries such as China, India, and Japan, has seen a surge in the demand for tryptophan due to the growth of livestock farming and aquaculture. For instance, India has the largest livestock population, with approximately 535.78 million animals.

Additionally, China, as the world’s largest producer and consumer of animal feed, accounts for a significant portion of tryptophan usage, particularly in poultry and swine production. Similarly, China consumes approximately one-third of the world’s meat, making it the largest meat-consuming nation globally. This constant and increased consumption of meat and dairy products is further driving the need for high-quality animal feed.

Furthermore, the demand for dietary supplements in countries such as Japan and South Korea has risen as consumers seek natural solutions to improve mental health, sleep quality, and overall well-being. The combined growth in both the animal feed and supplement sectors, along with the growing trend of health consciousness, makes the Asia Pacific a key hub for tryptophan consumption.

Tryptophan Market Regional AnalysisTryptophan Market Regional Analysis

Key Regions and Countries

  • North America
  • Europe
    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Russia & CIS
    • Rest of Europe
  • APAC
    • China
    • Japan
    • South Korea
    • India
    • ASEAN
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of MEA

Key Players Analysis

Major global participants in the tryptophan market, including Ajinomoto Co., Inc., Evonik Industries AG, CJ CheilJedang Corporation, & others, are pursuing strategies centered on technological innovation, large-scale production, and vertical integration to secure market dominance. These companies invest heavily in advanced fermentation technologies to enhance yield and reduce costs, while also expanding global production facilities to meet rising demand in feed, pharmaceutical, and nutraceutical sectors. Strategic collaborations, mergers, and distribution partnerships broaden market reach, while sustainability initiatives and product quality certifications strengthen brand credibility and customer loyalty worldwide.

Ajinomoto Co. is a Japanese multinational food and biotechnology company that is known for its expertise in amino acid technologies and its comprehensive range of products, including seasonings. The company has historically expanded its global supply and production of feed-use amino acids, aiming to support regional animal nutrition needs worldwide.

CJ CheilJedang is a global South Korean company with divisions in food, food ingredients, bio, and feed, that is a leading producer of the amino acid tryptophan through its CJ BIO unit. It utilizes advanced fermentation technology to produce high-quality tryptophan, with its Bestamino brand being a leader in the global market.

Evonik is a global specialty chemicals company and a leader in animal nutrition, being the exclusive manufacturer of all four essential amino acids for animal feed, including TrypAMINO (L-tryptophan). The company’s strategy focuses on profitable growth and value creation by leveraging innovation in key areas such as health, nutrition, and resource efficiency.

The major players in the industry

  • Ajinomoto Co., Inc
  • CJ CheilJedang Corp.
  • Evonik Industries AG
  • AMINO GmbH
  • Kyowa Hakko Bio Ltd.
  • Senova Technology Co., Ltd.
  • Central Drug House
  • Glanbia plc
  • Daesang Corporation
  • Archer Daniels Midland
  • Others

Key Developments

  • In May 2023, CJ BIO, the biotechnology business unit of CJ CheilJedang Corp., announced that the 10,000-ton/year tryptophan capacity increase at its site in Piracicaba, Brazil, came online, bringing its capacity to 50,000 tons/year.

Report Scope



Source link

1 10, 2025

XRP Price Prediction: XRP ETF Updates As This Viral Crypto Sets New Records, Raising Over $26.8 Million

By |2025-10-01T16:06:51+03:00October 1, 2025|Crypto News, News|0 Comments

XRP is back in focus as fresh ETF updates spark optimism among traders, with investors weighing how new institutional inflows could shape the next breakout. At the same time, attention is shifting to Remittix, the viral payments token that just set new crypto records by raising over $26.8 million and selling more than 673 million tokens. Analysts now compare Remittix’s momentum to XRP’s early rise.

XRP Price Prediction Signals Undervaluation Ahead

XRP price today is holding steady at $2.90 after bouncing strongly from its $2.50 support zone, with buyers showing resilience in the face of market volatility. This renewed strength has sparked optimism across XRP news, as traders eye a potential repeat of past Q4 rallies. On-chain signals also point to growing demand, with a lower NVT ratio suggesting the asset could be undervalued at current levels.

For bulls, the short-term test is at $2.98, and the additional higher targets are at $3.14 and $3.30. Any further breakout will open the door to $3.66, and longer-term speculation suggests that XRP may hit $5 in the case of continued momentum. 

XRP Price Prediction: XRP ETF Updates As This Viral Crypto Sets New Records, Raising Over .8 Million

Historical patterns show that Ripple price prediction cycles often align with institutional inflows and regulatory clarity, both of which remain hot topics as ETF decisions loom.

While XRP price prediction models highlight opportunity, analysts caution that losing support at $2.70 could stall progress and drag the coin lower. Still, with whales accumulating and ETF speculation growing, Ripple news suggests the stage may be set for a decisive move.

Remittix Ranks Number One For Pre-Launch Tokens On CertiK

Remittix has captured the spotlight after smashing through $26.8 million in funding, selling more than 673 million tokens at $0.1130 each. This milestone puts the project in the same conversation as established giants in cross-border finance, while excitement grows around comparisons to Ripple and XRP. 

Remittix is unique in that it aims to provide an easy way to transfer money all over the world, providing speed, security, and low-cost services through blockchain technology.

  • Over $26.8 million raised in presale, signaling strong investor confidence
  • More than 673 million RTX tokens sold, priced at $0.1130 each
  • Beta testing for the Remittix wallet now live with select community members
  • Referral program offering 15% back in USDT for every new buyer introduced

The Remittix team has also confirmed major listings, with BitMart revealed as the first CEX partner after the $20 million milestone and LBank joining soon after. Coupled with CertiK verification and a #1 pre-launch token ranking, this progress strengthens trust within the community. 

While XRP price prediction remains a hot debate amid ETF speculation, many analysts argue that Remittix’s real-world utility gives it the edge to become a true Ripple 2.0.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/ 

Socials: https://linktr.ee/remittix 

$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway 

Source link

1 10, 2025

The EURCHF attempts to activate the bullish track– Forecast today – 01-10-2025

By |2025-10-01T14:33:47+03:00October 1, 2025|Forex News, News|0 Comments


Natural gas price activated with the main indicators’ positivity, breaching the resistance at $3.290 level, to settle within the main bullish channel’s levels, achieving some gains by reaching 3.365.

 

Forming main support at $3.280 level, besides the continuation of providing positive momentum by the main indicators, we expect forming a new bullish rally to surpass $3.410 level, to target the next station at 3.350.

 

The expected trading range for today is between $3.300 and $3.530

 

Trend forecast: Bullish





Source link

1 10, 2025

The EURJPY presses on the extra support– Forecast today – 01-10-2025

By |2025-10-01T14:28:55+03:00October 1, 2025|Forex News, News|0 Comments

Copper price settled above $4.7500 level, increasing the efficiency of the suggested bullish trend, hitting 4.8500 level again.

 

The unionism of the main indicators to provide positive momentum by forming extra support at $4.5600 level, these factors will support renewing the bullish attempts, that target $4.9500 level reaching the next main target near 5.3200.

 

The expected trading range for today is between $4.6700 and 4.9500

 

Trend forecast: Bullish

 



Source link

1 10, 2025

Keyslim Drops Reviews 2025 – Weight Loss Supplement Expert’s Take

By |2025-10-01T14:24:46+03:00October 1, 2025|Dietary Supplements News, News|0 Comments




Keyslim Drops Reviews 2025 – Weight Loss Supplement Expert’s Take

Keyslim Drops Reviews 2025: The struggle with weight loss isn’t really about knowing what to do. Most people know the basics—eat better, move more, get enough sleep. The hard part is sticking with it when cravings kick in, energy dips, and the scale barely moves. I’ve seen this pattern play out over and over in clients. They start motivated, but two weeks in, reality bites. That’s why supplements keep drawing attention—not as miracle solutions, but as potential supports when discipline alone isn’t enough.

Keyslim Drops has been showing up more in conversations lately. I was curious, so I dug into its claims and structure. What stood out wasn’t just the ingredient list, but the way it’s packaged: a liquid formula meant to act faster and fit into daily routines more easily than capsules. And I’ll be honest, convenience matters. If something is easier to take, compliance goes up. And compliance is half the battle.

What is Keyslim Drops?

Keyslim Drops is positioned as a 24-in-1 liquid supplement designed for weight management. It aims to do three things: calm cravings, accelerate metabolism, and provide long-term balance. In plain terms, it’s marketed as a tool for people who struggle with overeating, sluggish calorie burn, and staying on track.

What I find interesting is the choice to make it a dropper-based liquid. In my practice, people often complain about pill fatigue—especially those juggling multiple daily medications or vitamins. A sublingual liquid, theoretically, absorbs more efficiently and bypasses the usual digestive hurdles. That’s appealing to anyone who wants quicker results (or at least the feeling of quicker results).

Is it revolutionary? Not exactly. But the packaging, combined with the “24 active ingredients” hook, gives it a distinct angle in a crowded space.

Full Disclosure and Manufacturer Website

How does Keyslim Drops Work?

The company describes Keyslim Drops in three stages of action:

1. Appetite control – using compounds that target cravings and stabilize blood sugar.

2. Metabolism boost – leveraging natural stimulants and amino acids that may increase energy expenditure.

3. Long-term support – with adaptogens and mood-balancing compounds that could help sustain consistency.

From my perspective, this three-part framework isn’t groundbreaking, but it’s smart marketing. People like to see a structured plan, even in a supplement.

Take stage one: Gymnema Sylvestre, nicknamed the “sugar destroyer,” has been studied for its effect on reducing sweet cravings. Chromium, another inclusion, is often touted for blood sugar support. Together, they’re meant to dial down that voice in your head that says “just one cookie won’t hurt.”

Stage two leans on familiar fat-burners like green tea extract and guarana. Those do contain caffeine, so expect a mild stimulant effect. I remember one client telling me she actually preferred that buzz—it gave her the nudge to get through afternoon workouts. Not everyone feels the same way, but still, it’s a notable aspect.

Stage three is where things get less talked about: adaptogens like maca and ginseng. These don’t melt fat directly, but they may help keep stress, mood, and energy steadier. Why does that matter? Well, people often fall off a diet when stress peaks. A calmer system stays the course longer.

What are the ingredients of Keyslim Drops?

The ingredient roster is lengthy—24 total—and not all of them carry equal weight. But some deserve attention:

– L-Ornithine & L-Glutamine: amino acids tied to energy and muscle recovery.

– Gymnema Sylvestre: traditionally used to curb sugar cravings.

– Green Tea Extract & Guarana: natural stimulants for thermogenesis.

– African Mango Extract & Raspberry Ketones: trendy names in weight loss, though human data is mixed.

– Maca Root, Ginseng, Eleuthero: adaptogens thought to support mood and stamina.

– GABA: more about relaxation than fat burning, but stress reduction indirectly helps with weight control.

Now, here’s the catch. The label doesn’t show dosages. That’s a blind spot. As a researcher, I normally insist on transparency—100 mg of green tea isn’t the same as 500 mg. But for the average consumer, the appeal is in the blend rather than the exact math. (And let’s be honest, most people don’t dig into milligrams when buying a fat burner.)

What are the benefits of Keyslim Drops?

The potential benefits—if the formula works as positioned—are straightforward:

– Reduced food cravings, particularly for sweets and carbs.

– Boosted metabolism and calorie expenditure.

– Steadier energy and mood, which indirectly supports weight loss consistency.

– Plant-based, gluten-free, and non-GMO profile, making it suitable for a wide audience.

A small but important benefit? Ease of use. A few drops a day feels less intimidating than swallowing multiple capsules. I’ve noticed people stick to liquids better—maybe it feels less “medical” and more like part of a routine. That kind of psychological edge shouldn’t be underestimated.

Keyslim Drops Pros and Cons

Keyslim Drops Pros:

– 24 active ingredients covering appetite, metabolism, and long-term support.

– Vegan, gluten-free, non-GMO, and no synthetic fillers.

– Liquid format, easier for those tired of pills.

– Comes with digital health guides as bonuses on larger packages.

– 60-day money-back guarantee reduces risk.

Keyslim Drops Cons:

– No published ingredient dosages.

– Relies on trendy extracts without full clinical validation as a complete formula.

– Contains caffeine from guarana/green tea—some may find it too stimulating.

From my perspective, the lack of dosage detail is the most notable drawback. Everything else is par for the course in supplement land.

Keyslim Drops Price and Guarantee

The pricing is tiered:

– Single bottle: $79 + shipping.

– Three bottles: $59 each, free U.S. shipping.

– Six bottles: $49 each, free U.S. shipping.

Refunds are covered by a 60-day money-back guarantee—though you do have to ship bottles back to a U.S. address in Colorado. For domestic buyers, that’s fine. For international buyers, it’s a bit less convenient.

I’ve seen worse refund setups in this industry. At least this one is clear.

Keyslim Drops Reviews Final Verdict

In nine years of working around supplements, I’ve learned that no single product is a silver bullet. But certain formulas can genuinely help when used as part of a bigger plan. Keyslim Drops, with its multi-ingredient design and user-friendly liquid form, has carved itself a spot as one of the more approachable options in 2025.

It won’t replace a balanced diet, and it won’t override poor habits. But for someone looking for an extra layer of support—especially someone who struggles with cravings or pill fatigue—it has clear appeal.

If you’re considering it, the 60-day guarantee makes the decision less risky. Try it, monitor how your body responds, and decide from there. At the end of the day, supplements aren’t magic wands. They’re tools. And in the right hands, the right tool can make the job a lot easier.

READ MORE DETAILS IN THIS ARTICLE – KEYSLIM DROPS IN-DEPTH REVIEWS 2025

Thank you fro reading this Keyslim Drops Reviews 2025. Feel free to ask should you have any questions, I’ll be more than glad to help.



Source link

1 10, 2025

Record Quarterly Close Could Trigger a $15 Rally – Just Like the 37,800% Run in 2017

By |2025-10-01T14:05:29+03:00October 1, 2025|Crypto News, News|0 Comments

The XRP quarterly chart has flipped green for the first time since 2017, a potential bullish setup for XRP price predictions if history repeats.

The 28% gains observed over the past 3 months could be the final leg in a historic breakout setup for the altcoin, as per analysis by Miky Bull Crypto.

Mirroring the 2017 setup that preceded a 37,800% rally in the XRP price, this quarterly close has confirmed a break above a multi-year resistance zone as technical indicators flip bullish.

The analysts anticipate a potential $15 target, a credible argument as market narratives continue to favor a Q4 bull run.

XRP is deepening its foothold in U.S. TradFi markets, with the new SEC generic listing standards for crypto ETPs paving the way for multiple issuers to fast-track approval.

The U.S. macro narrative adds fuel. Markets are anticipating a 0.5% interest rate ease before year-end, with the potential to stimulate demand for risk assets like XRP.

XRP Price Prediction: Is $15 XRP Possible This Cycle?

The daily timeframe adds weight to the setup, with a cup-and-handle pattern forming since the start of the year now nearing its apex.

A triple bottom has developed along the handle’s lower boundary at $2.70, a strong reversal structure that positions the latest bounce as the start of a breakout move.

XRP / USD 1-day chart, cup-and-handle pattern nears apex. Source: TradingView.

Momentum indicators reinforce this outlook. The RSI is building towards a break above the neutral 50 line, suggesting buyers are regaining control.

The MACD histogram shows a similar potential trend shift, reversing towards a golden cross above the signal line, hinting at the early stages of a new uptrend.

The key threshold for a confirmed breakout sits around $3.60. Once flipped to support, the cup-and-handle pattern can realise its full breakout momentum in a 165% move to $7.50.

And with U.S. interest rate cuts, more spot ETF approvals, and potential 401(k) inclusion stacking as catalysts into 2026, the rally could extend 430% to achieve Miky’s $15 target.

Holders Are Moving to a New Wallet This Bull Run – Here’s Why

As accumulation ramps up, long-term holders are pulling assets off exchanges and into wallets like MetaMask and Exodus, and increasingly, Best Wallet ($BEST).

Its appeal lies in forward-looking features built for bull markets. The “Upcoming Tokens” tool acts as a crypto screener, flagging early projects before they go mainstream, which is where the biggest gains are found.

But the utility doesn’t stop there. It taps into this cycle’s hottest narrative: TradFi.

Its native Best Card bridges TradFi and Web3, enabling stablecoin payments anywhere Mastercard is accepted.

For these reasons, its native token $BEST is poised to capture significant momentum this bull run.

Investors are already taking early positions with $15.5 million raised in presale so far.

You can secure your Best Wallet Tokens ($BEST) on the official website. With the demand of exchanges still untapped, current prices stand as a potential discount.

To learn more about Best Wallet, follow its official X (formerly Twitter) and Telegram.

Click Here to Participate in the Presale

The post XRP Price Prediction: Record Quarterly Close Could Trigger a $15 Rally – Just Like the 37,800% Run in 2017 appeared first on Cryptonews.



Source link

1 10, 2025

Copper price fluctuates above the barrier– Forecast today – 01-10-2025

By |2025-10-01T12:32:53+03:00October 1, 2025|Forex News, News|0 Comments


The (ETHUSD) price settled with gains in its last intraday trading, amid the dominance of the bullish correctional trend on the short-term basis and its trading alongside supportive trend line for this track, with the continuation of the positive pressure due to its trading above EMA50, representing dynamic support that helps the price rise, with the positive divergence on the relative strength indicators, after reaching oversold levels, exaggeratedly compared to the price move, with the emergence of the positive signals from them.

 

 

VIP Trading Signals Performance by BestTradingSignal.com (September 22–26, 2025)


 

Get high-accuracy trading signals delivered directly to your Telegram. Subscribe to specialized packages tailored for the world’s top markets:


 

 

Full VIP signals performance report for September 22–26, 2025:

  View Full Performance Report


 





Source link

Go to Top